Cargando…
Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review
The purinergic P2Y12 receptor regulates microglial activation, resulting in persistence and aggravation of pain in neuropathic and nociceptive pain models. We conducted a retrospective chart review to explore the analgesic potency of the P2Y12 receptor-specific antagonist, clopidogrel, for clinical...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344612/ https://www.ncbi.nlm.nih.gov/pubmed/32580286 http://dx.doi.org/10.3390/life10060092 |
_version_ | 1783555984487088128 |
---|---|
author | Tsuchida, Rikuhei Sumitani, Masahiko Abe, Hiroaki Ando, Masae Saita, Kosuke Hattori, Kohshi Mietani, Kazuhito Inoue, Reo Uchida, Kanji |
author_facet | Tsuchida, Rikuhei Sumitani, Masahiko Abe, Hiroaki Ando, Masae Saita, Kosuke Hattori, Kohshi Mietani, Kazuhito Inoue, Reo Uchida, Kanji |
author_sort | Tsuchida, Rikuhei |
collection | PubMed |
description | The purinergic P2Y12 receptor regulates microglial activation, resulting in persistence and aggravation of pain in neuropathic and nociceptive pain models. We conducted a retrospective chart review to explore the analgesic potency of the P2Y12 receptor-specific antagonist, clopidogrel, for clinical management of postoperative pain in patients who underwent abdominal surgery. Twenty-seven patients with cardiovascular comorbidities, who underwent laparoscopic abdominal surgery and had ceased aspirin (ASP, n = 17) or clopidogrel (CLP, n = 10) for 14 days pre-operatively, were enrolled retrospectively. In both groups, the number of opioids and non-steroidal anti-inflammatory drugs (NSAIDs) consumed for managing postoperative pain was compared using the chi-square test and Mann–Whitney test. Our results showed that from postoperative day (POD) 0 to POD 3, the average numerical rating reflecting the postoperative pain was comparable between the two groups (CLP: 4.0 ± 1.4 vs. ASP: 3.7 ± 0.8, P-value = 0.56). However, at POD 7, opioid consumption in the CLP-treated group (fentanyl-equivalent dose: 0.49 ± 0.56 mg) was significantly lower than that in the ASP-treated group (1.48 ± 1.35 mg, P-value = 0.037). After reaching a stable state by repeated systemic administration, clopidogrel sustained the analgesic efficacy for a certain period. In conclusion, microglial P2Y12 receptors may mediate signal transduction of postoperative nociceptive pain and enhance clinical opioid analgesia. |
format | Online Article Text |
id | pubmed-7344612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73446122020-07-09 Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review Tsuchida, Rikuhei Sumitani, Masahiko Abe, Hiroaki Ando, Masae Saita, Kosuke Hattori, Kohshi Mietani, Kazuhito Inoue, Reo Uchida, Kanji Life (Basel) Communication The purinergic P2Y12 receptor regulates microglial activation, resulting in persistence and aggravation of pain in neuropathic and nociceptive pain models. We conducted a retrospective chart review to explore the analgesic potency of the P2Y12 receptor-specific antagonist, clopidogrel, for clinical management of postoperative pain in patients who underwent abdominal surgery. Twenty-seven patients with cardiovascular comorbidities, who underwent laparoscopic abdominal surgery and had ceased aspirin (ASP, n = 17) or clopidogrel (CLP, n = 10) for 14 days pre-operatively, were enrolled retrospectively. In both groups, the number of opioids and non-steroidal anti-inflammatory drugs (NSAIDs) consumed for managing postoperative pain was compared using the chi-square test and Mann–Whitney test. Our results showed that from postoperative day (POD) 0 to POD 3, the average numerical rating reflecting the postoperative pain was comparable between the two groups (CLP: 4.0 ± 1.4 vs. ASP: 3.7 ± 0.8, P-value = 0.56). However, at POD 7, opioid consumption in the CLP-treated group (fentanyl-equivalent dose: 0.49 ± 0.56 mg) was significantly lower than that in the ASP-treated group (1.48 ± 1.35 mg, P-value = 0.037). After reaching a stable state by repeated systemic administration, clopidogrel sustained the analgesic efficacy for a certain period. In conclusion, microglial P2Y12 receptors may mediate signal transduction of postoperative nociceptive pain and enhance clinical opioid analgesia. MDPI 2020-06-22 /pmc/articles/PMC7344612/ /pubmed/32580286 http://dx.doi.org/10.3390/life10060092 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Tsuchida, Rikuhei Sumitani, Masahiko Abe, Hiroaki Ando, Masae Saita, Kosuke Hattori, Kohshi Mietani, Kazuhito Inoue, Reo Uchida, Kanji Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review |
title | Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review |
title_full | Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review |
title_fullStr | Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review |
title_full_unstemmed | Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review |
title_short | Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Can Prevent Severe Postoperative Pain: A Retrospective Chart Review |
title_sort | clopidogrel, an adp-p2y12 receptor antagonist, can prevent severe postoperative pain: a retrospective chart review |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344612/ https://www.ncbi.nlm.nih.gov/pubmed/32580286 http://dx.doi.org/10.3390/life10060092 |
work_keys_str_mv | AT tsuchidarikuhei clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview AT sumitanimasahiko clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview AT abehiroaki clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview AT andomasae clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview AT saitakosuke clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview AT hattorikohshi clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview AT mietanikazuhito clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview AT inouereo clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview AT uchidakanji clopidogrelanadpp2y12receptorantagonistcanpreventseverepostoperativepainaretrospectivechartreview |